Cargando…
Prognostic nomogram for nonresectable pancreatic cancer treated with gemcitabine-based chemotherapy
BACKGROUND: A nomogram is progressively being used as a useful predictive tool for cancer prognosis. A nomogram to predict survival in nonresectable pancreatic cancer treated with chemotherapy has not been reported. METHODS: Using prospectively collected data on patients with nonresectable pancreati...
Autores principales: | Hamada, T, Nakai, Y, Yasunaga, H, Isayama, H, Matsui, H, Takahara, N, Sasaki, T, Takagi, K, Watanabe, T, Yagioka, H, Kogure, H, Arizumi, T, Yamamoto, N, Ito, Y, Hirano, K, Tsujino, T, Tada, M, Koike, K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992497/ https://www.ncbi.nlm.nih.gov/pubmed/24642625 http://dx.doi.org/10.1038/bjc.2014.131 |
Ejemplares similares
-
Inhibition of renin–angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine
por: Nakai, Y, et al.
Publicado: (2010) -
A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP study
por: Nakai, Y, et al.
Publicado: (2012) -
A Novel, Fully Covered Laser-Cut Nitinol Stent with Antimigration Properties for Nonresectable Distal Malignant Biliary Obstruction: A Multicenter Feasibility Study
por: Isayama, Hiroyuki, et al.
Publicado: (2013) -
Multicenter retrospective and comparative study of 5-minute versus 15-second endoscopic papillary balloon dilation for removal of bile duct stones
por: Hakuta, Ryunosuke, et al.
Publicado: (2017) -
Antireflux Metal Stent as a First-Line Metal Stent for Distal Malignant Biliary Obstruction: A Pilot Study
por: Hamada, Tsuyoshi, et al.
Publicado: (2017)